Quality Improvement and/or Research Grant Request for Proposals: Migraine Competitive Grant Program – Migraine and Women's Health
This grant funds collaborative research and quality improvement projects to advance scientific understanding and care for women with migraine in the US.
Funder: Pfizer Inc.
Due Dates: May 5, 2026 (LOI submission) | August 28, 2026 (Full proposal, by invitation)
Funding Amounts: Up to $200,000 per project (max 2 years); total program budget approx. $500,000; 28% overhead cap.
Summary: Supports collaborative quality improvement and research projects to advance migraine care and outcomes for women in the US.
Key Information: LOI is required; only invited applicants may submit full proposals.
Description
This grant program, a collaboration between Pfizer and the American Headache Society, supports innovative quality improvement and research projects focused on migraine and women's health in the United States. The initiative aims to advance scientific understanding, improve patient outcomes, and address care gaps for women affected by migraine. Eligible projects may be pre-clinical, clinical, or non-clinical, and should generate actionable, measurable results that enhance the diagnosis, treatment, management, or overall standards of care for women with migraine. Multidisciplinary and collaborative approaches are encouraged, with priority given to quality improvement and clinical research proposals.
